Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Douglas Greene
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Physiology
Anatomy
Living Beings
Procedures
Sign-in to see full Profile
Network (preview)
27
Sima, Anders
26
Stevens, Martin
14
Feldman, Eva
9
Thomas, Thommey
7
Obrosova, Irina
6
Killen, Paul
6
Larkin, Dennis
4
Fathallah, Lamia
4
Bril, Vera
4
Van Huysen, Carol
3
Porcellati, Francesca
3
Chakrabarti, Subrata
3
Cao, X
3
Del Monte, Monte
3
Herman, William
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Douglas Greene (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2006: Martin Catherine L; Albers James; Herman William H; Cleary Patricia; Waberski Barbara; Greene Douglas A; Stevens Martin J; Feldman Eva L;
Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion.
Diabetes care 2006;29(2):340-4.
-
2005: Nakashima Eitaro; Pop-Busui Rodica; Towns Roberto; Thomas Thommey P; Hosaka Yoshiuki; Nakamura Jiro; Greene Douglas A; Killen Paul D; Schroeder Justin; Larkin Dennis D; Ho Yuk Lam; Stevens Martin J
Regulation of the human taurine transporter by oxidative stress in retinal pigment epithelial cells stably transformed to overexpress aldose reductase.
Antioxidants & redox signaling 2005;7(11-12):1530-42.
-
2005: Stevens Martin J; Larkin Dennis D; Feldman Eva L; DelMonte Monte A; Greene Douglas A
Establishment, maintenance, and transfection of in vitro cultures of human retinal pigment epithelium.
Methods in molecular medicine 2005;107():343-51.
-
2003: Sullivan K A; Brown M S; Harmon L; Greene D A
Digital electron microscopic examination of human sural nerve biopsies.
Journal of the peripheral nervous system : JPNS 2003;8(4):260-70.
-
2003: Thrainsdottir Soley; Malik Rayez A; Dahlin Lars B; Wiksell Peter; Eriksson Karl F; Rosén Ingmar; Petersson Jesper; Greene Douglas A; Sundkvist Göran
Endoneurial capillary abnormalities presage deterioration of glucose tolerance and accompany peripheral neuropathy in man.
Diabetes 2003;52(10):2615-22.
-
2003: Ilag Liza L; Martin Catherine L; Tabaei Bahman P; Isaman Deanna J M; Burke Ray; Greene Douglas A; Herman William H
Improving diabetes processes of care in managed care.
Diabetes care 2003;26(10):2722-7.
-
2002: Viberti Giancarlo; Kahn Steven E; Greene Douglas A; Herman William H; Zinman Bernard; Holman Rury R; Haffner Steven M; Levy Daniel; Lachin John M; Berry Rhona A; Heise Mark A; Jones Nigel P; Freed Martin I
A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes.
Diabetes care 2002;25(10):1737-43.
-
2002: Pop-Busui Rodica; Marinescu Victor; Van Huysen Carol; Li Fei; Sullivan Kelli; Greene Douglas A; Larkin Dennis; Stevens Martin J
Dissection of metabolic, vascular, and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration.
Diabetes 2002;51(8):2619-28.
-
2002: Obrosova Irina G; Van Huysen Carol; Fathallah Lamia; Cao Xianghui Cao; Greene Douglas A; Stevens Martin J
An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2002;16(1):123-5.
-
2000: Obrosova I G; Van Huysen C; Fathallah L; Cao X; Stevens M J; Greene D A
Evaluation of alpha(1)-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2000;14(11):1548-58.
-
2000: Stevens M J; Obrosova I; Cao X; Van Huysen C; Greene D A
Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy.
Diabetes 2000;49(6):1006-15.
-
2000: Obrosova I G; Fathallah L; Greene D A
Early changes in lipid peroxidation and antioxidative defense in diabetic rat retina: effect of DL-alpha-lipoic acid.
European journal of pharmacology 2000;398(1):139-46.
-
2000: Sundkvist G; Dahlin L B; Nilsson H; Eriksson K F; Lindgärde F; Rosén I; Lattimer S A; Sima A A; Sullivan K; Greene D A
Sorbitol and myo-inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance.
Diabetic medicine : a journal of the British Diabetic Association 2000;17(4):259-68.
-
2000: Harati Y; Gooch C; Swenson M; Edelman S V; Greene D; Raskin P; Donofrio P; Cornblath D; Olson W H; Kamin M
Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy.
Journal of diabetes and its complications 2000;14(2):65-70.
-
1999: Obrosova I G; Fathallah L; Lang H J; Greene D A
Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study.
Diabetologia 1999;42(10):1187-94.
-
1999: Greene D A; Stevens M J; Feldman E L
Diabetic neuropathy: scope of the syndrome.
The American journal of medicine 1999;107(2B):2S-8S.
-
1999: Greene D A; Arezzo J C; Brown M B
Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group.
Neurology 1999;53(3):580-91.
-
1999: Kato K; Thomas T P; Stevens M J; Greene D A; Nakamura J
2-Chloroadenosine reverses hyperglycemia-induced inhibition of phosphoinositide synthesis in cultured human retinal pigment epithelial cells and prevents reduced nerve conduction velocity in diabetic rats.
Metabolism: clinical and experimental 1999;48(7):827-33.
-
1999: Greene D A; Stevens M J; Obrosova I; Feldman E L
Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy.
European journal of pharmacology 1999;375(1-3):217-23.
-
1999: Porcellati F; Hosaka Y; Hlaing T; Togawa M; Larkin D D; Karihaloo A; Stevens M J; Killen P D; Greene D A
Alternate splicing in human Na+-MI cotransporter gene yields differentially regulated transport isoforms.
The American journal of physiology 1999;276(6 Pt 1):C1325-37.
-
1999: Hogikyan R V; Wald J J; Feldman E L; Greene D A; Halter J B; Supiano M A
Acute effects of adrenergic-mediated ischemia on nerve conduction in subjects with type 2 diabetes.
Metabolism: clinical and experimental 1999;48(4):495-500.
-
1998: Obrosova I; Cao X; Greene D A; Stevens M J
Diabetes-induced changes in lens antioxidant status, glucose utilization and energy metabolism: effect of DL-alpha-lipoic acid.
Diabetologia 1998;41(12):1442-50.
-
1998: Harati Y; Gooch C; Swenson M; Edelman S; Greene D; Raskin P; Donofrio P; Cornblath D; Sachdeo R; Siu C O; Kamin M
Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy.
Neurology 1998;50(6):1842-6.
-
1998: Hogikyan R V; Galecki A T; Pitt B; Halter J B; Greene D A; Supiano M A
Specific impairment of endothelium-dependent vasodilation in subjects with type 2 diabetes independent of obesity.
The Journal of clinical endocrinology and metabolism 1998;83(6):1946-52.
-
1998: Porcellati F; Hlaing T; Togawa M; Stevens M J; Larkin D D; Hosaka Y; Glover T W; Henry D N; Greene D A; Killen P D
Human Na(+)-myo-inositol cotransporter gene: alternate splicing generates diverse transcripts.
The American journal of physiology 1998;274(5 Pt 1):C1215-25.
-
1998: Magnani P; Thomas T P; Tennekoon G; DeVries G H; Greene D A; Brosius F C
Regulation of glucose transport in cultured Schwann cells.
Journal of the peripheral nervous system : JPNS 1998;3(1):28-36.
-
1997: Karihaloo A; Kato K; Greene D A; Thomas T P
Protein kinase and Ca2+ modulation of myo-inositol transport in cultured retinal pigment epithelial cells.
The American journal of physiology 1997;273(2 Pt 1):C671-8.
-
1997: Sima A A; Dunlap J A; Davidson E P; Wiese T J; Lightle R L; Greene D A; Yorek M A
Supplemental myo-inositol prevents L-fucose-induced diabetic neuropathy.
Diabetes 1997;46(2):301-6.
-
1997: Feldman E L; Stevens M J; Greene D A
Pathogenesis of diabetic neuropathy.
Clinical neuroscience (New York, N.Y.) 1997;4(6):365-70.
-
1996: Magnani P; Cherian P V; Gould G W; Greene D A; Sima A A; Brosius F C
Glucose transporters in rat peripheral nerve: paranodal expression of GLUT1 and GLUT3.
Metabolism: clinical and experimental 1996;45(12):1466-73.
-
1996: Stevens M J; Lattimer S A; Feldman E L; Helton E D; Millington D S; Sima A A; Greene D A
Acetyl-L-carnitine deficiency as a cause of altered nerve myo-inositol content, Na,K-ATPase activity, and motor conduction velocity in the streptozotocin-diabetic rat.
Metabolism: clinical and experimental 1996;45(7):865-72.
-
1996: Sima A A; Ristic H; Merry A; Kamijo M; Lattimer S A; Stevens M J; Greene D A
Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat.
The Journal of clinical investigation 1996;97(8):1900-7.
-
1996: Shindo H; Thomas T P; Larkin D D; Karihaloo A K; Inada H; Onaya T; Stevens M J; Greene D A
Modulation of basal nitric oxide-dependent cyclic-GMP production by ambient glucose, myo-inositol, and protein kinase C in SH-SY5Y human neuroblastoma cells.
The Journal of clinical investigation 1996;97(3):736-45.
-
1996: Albers J W; Brown M B; Sima A A; Greene D A
Nerve conduction measures in mild diabetic neuropathy in the Early Diabetes Intervention Trial: the effects of age, sex, type of diabetes, disease duration, and anthropometric factors. Tolrestat Study Group for the Early Diabetes Intervention Trial.
Neurology 1996;46(1):85-91.
-
1995: Stevens M J; Feldman E L; Greene D A
The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects.
Diabetic medicine : a journal of the British Diabetic Association 1995;12(7):566-79.
-
1995: Sima A A; Greene D A
Diabetic neuropathy in the elderly.
Drugs & aging 1995;6(2):125-35.
-
1994: Nakamura J; Lattimer S A; Greene D A
Transphosphatidylation of sugar alcohols and its implications for the pathogenesis of diabetic complications.
Diabetologia 1994;37(11):1147-53.
-
1994: Feldman E L; Stevens M J; Thomas P K; Brown M B; Canal N; Greene D A
A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy.
Diabetes care 1994;17(11):1281-9.
-
1994: Stevens M J; Dananberg J; Feldman E L; Lattimer S A; Kamijo M; Thomas T P; Shindo H; Sima A A; Greene D A
The linked roles of nitric oxide, aldose reductase and, (Na+,K+)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat.
The Journal of clinical investigation 1994;94(2):853-9.
-
1994: Thomas T P; Porcellati F; Kato K; Stevens M J; Sherman W R; Greene D A
Effects of glucose on sorbitol pathway activation, cellular redox, and metabolism of myo-inositol, phosphoinositide, and diacylglycerol in cultured human retinal pigment epithelial cells.
The Journal of clinical investigation 1994;93(6):2718-24.
-
1993: Thomas T P; Feldman E L; Nakamura J; Kato K; Lien M; Stevens M J; Greene D A
Ambient glucose and aldose reductase-induced myo-inositol depletion modulate basal and carbachol-stimulated inositol phospholipid metabolism and diacylglycerol accumulation in human retinal pigment epithelial cells in culture.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(20):9712-6.
-
1993: Yorek M A; Wiese T J; Davidson E P; Dunlap J A; Stefani M R; Conner C E; Lattimer S A; Kamijo M; Greene D A; Sima A A
Reduced motor nerve conduction velocity and Na(+)-K(+)-ATPase activity in rats maintained on L-fucose diet. Reversal by myo-inositol supplementation.
Diabetes 1993;42(10):1401-6.
-
1993: Greene D A; Sima A A; Stevens M J; Feldman E L; Killen P D; Henry D N; Thomas T; Dananberg J; Lattimer S A
Aldose reductase inhibitors: an approach to the treatment of diabetic nerve damage.
Diabetes/metabolism reviews 1993;9(3):189-217.
-
1993: Stevens M J; Henry D N; Thomas T P; Killen P D; Greene D A
Aldose reductase gene expression and osmotic dysregulation in cultured human retinal pigment epithelial cells.
The American journal of physiology 1993;265(3 Pt 1):E428-38.
-
1993: Henry D N; Del Monte M; Greene D A; Killen P D
Altered aldose reductase gene regulation in cultured human retinal pigment epithelial cells.
The Journal of clinical investigation 1993;92(2):617-23.
-
1993: Stevens M J; Lattimer S A; Kamijo M; Van Huysen C; Sima A A; Greene D A
Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat.
Diabetologia 1993;36(7):608-14.
-
1993: Sima A A; Greene D A; Brown M B; Hohman T C; Hicks D; Graepel G J; Bochenek W J; Beg M; Gonen B
Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy. The Tolrestat Study Group.
Journal of diabetes and its complications 1993;7(3):157-69.
-
1993: Sima A A; Prashar A; Nathaniel V; Bril V; Werb M R; Greene D A
Overt diabetic neuropathy: repair of axo-glial dysjunction and axonal atrophy by aldose reductase inhibition and its correlation to improvement in nerve conduction velocity.
Diabetic medicine : a journal of the British Diabetic Association 1993;10(2):115-21.
-
1993: Sima A A; Greene D A
Structural-functional interactions in the therapeutic response of diabetic neuropathy.
Diabetic medicine : a journal of the British Diabetic Association 1993;10 Suppl 2():33S-34S.
-
1992: Greene D A; Sima A A; Stevens M J; Feldman E L; Lattimer S A
Complications: neuropathy, pathogenetic considerations.
Diabetes care 1992;15(12):1902-25.
-
1992: Sima A A; Brown M B; Prashar A; Chakrabarti S; Laudadio C; Greene D A
The reproducibility and sensitivity of sural nerve morphometry in the assessment of diabetic peripheral polyneuropathy.
Diabetologia 1992;35(6):560-9.
-
1992: Nakamura J; Del Monte M A; Shewach D; Lattimer S A; Greene D A
Inhibition of phosphatidylinositol synthase by glucose in human retinal pigment epithelial cells.
The American journal of physiology 1992;262(4 Pt 1):E417-26.
-
1992: Greene D A
Effects of aldose reductase inhibitors on the progression of nerve fiber damage in diabetic neuropathy.
Journal of diabetes and its complications 1992;6(1):35-8.
-
1991: Del Monte M A; Rabbani R; Diaz T C; Lattimer S A; Nakamura J; Brennan M C; Greene D A
Sorbitol, myo-inositol, and rod outer segment phagocytosis in cultured hRPE cells exposed to glucose. In vitro model of myo-inositol depletion hypothesis of diabetic complications.
Diabetes 1991;40(10):1335-45.
-
1991: Sima A A; Nathaniel V; Prashar A; Bril V; Greene D A
Endoneurial microvessels in human diabetic neuropathy. Endothelial cell dysjunction and lack of treatment effect by aldose reductase inhibitor.
Diabetes 1991;40(9):1090-9.
-
1991: Feldman E L; Randolph A E; Johnston G C; DelMonte M A; Greene D A
Receptor-coupled phosphoinositide hydrolysis in human retinal pigment epithelium.
Journal of neurochemistry 1991;56(6):2094-100.
-
1991: Sima A A; Nathaniel V; Greene D A
Peripheral nerve repair following ARI treatment.
Advances in experimental medicine and biology 1991;291():265-70.
-
1990: Sima A A; Prashar A; Zhang W X; Chakrabarti S; Greene D A
Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat.
The Journal of clinical investigation 1990;85(5):1410-20.
-
1990: Zhang W X; Chakrabarti S; Greene D A; Sima A A
Diabetic autonomic neuropathy in BB rats and effect of ARI treatment on heart-rate variability and vagus nerve structure.
Diabetes 1990;39(5):613-8.
-
1989: Sima A A; Zhang W X; Greene D A
Diabetic and hypoglycemic neuropathy--a comparison in the BB rat.
Diabetes research and clinical practice 1989;6(4):279-96.
-
1989: Lattimer S A; Sima A A; Greene D A
In vitro correction of impaired Na+-K+-ATPase in diabetic nerve by protein kinase C agonists.
The American journal of physiology 1989;256(2 Pt 1):E264-9.
-
1989: Greene D A; Lattimer-Greene S; Sima A A
Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism.
Critical reviews in neurobiology 1989;5(2):143-219.
-
1988: Sima A A; Bril V; Nathaniel V; McEwen T A; Brown M B; Lattimer S A; Greene D A
Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil.
The New England journal of medicine 1988;319(9):548-55.
-
1988: Greene D A; Lattimer S A; Sima A A
Are disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy?
Diabetes 1988;37(6):688-93.
-
1988: Greene D A; Lattimer S A; Sima A A
Pathogenesis and prevention of diabetic neuropathy.
Diabetes/metabolism reviews 1988;4(3):201-21.
-
1988: Sima A A; Nathaniel V; Bril V; McEwen T A; Greene D A
Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy.
The Journal of clinical investigation 1988;81(2):349-64.
Sign-in to see more
